UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hematological findings and complications of COVID‐19

American journal of hematology, 2020-07, Vol.95 (7), p.834-847

2020

Volltextzugriff (PDF)

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study

The oncologist (Dayton, Ohio), 2017-10, Vol.22 (10), p.1222-1231

2017

Volltextzugriff (PDF)

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia

Infection, 2021-06, Vol.49 (3), p.559-562

2021

Volltextzugriff (PDF)

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

The oncologist (Dayton, Ohio), 2018-11, Vol.23 (11), p.1372-1381

2018

Volltextzugriff (PDF)

Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer

International journal of oncology, 2017-12, Vol.51 (6), p.1793-1800

2017

Volltextzugriff (PDF)

The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies

Critical reviews in oncogenesis, 2017, Vol.22 (3-4), p.219-248

2017

Volltextzugriff (PDF)

Modelling of thrombin generation under flow in realistic left anterior descending geometries

Medical engineering & physics, 2017-12, Vol.50, p.50-58

2017

Volltextzugriff (PDF)

Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells

International journal of oncology, 2017-12, Vol.51 (6), p.1747-1756

2017

Volltextzugriff (PDF)

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Bulletin du cancer, 2016-09, Vol.103 (9), p.764-775

2016

Volltextzugriff (PDF)

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

TH open : companion journal to thrombosis and haemostasis, 2022-04, Vol.6 (2), p.e89-e95

2022

Volltextzugriff (PDF)

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients

Therapeutics and clinical risk management, 2014-01, Vol.10 (default), p.423-436

2014

Volltextzugriff (PDF)

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

BMC cancer, 2014-12, Vol.14 (1), p.991-991, Article 991

2014

Volltextzugriff (PDF)

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

TH open : companion journal to thrombosis and haemostasis, 2019-07, Vol.3 (3), p.e309-e315

2019

Volltextzugriff (PDF)

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma

Clinical and applied thrombosis/hemostasis, 2018-11, Vol.24 (8), p.1347-1351

2018

Volltextzugriff (PDF)

Risk of venous thromboembolism in cancer patients: Reality, actuality and perspectives

Bulletin du cancer, 2016-09, Vol.103 (9), p.764

2016

Volltextzugriff (PDF)

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study

Blood cancer journal (New York), 2018-11, Vol.8 (11), p.102-13, Article 102

2018

Volltextzugriff (PDF)

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process

TH open : companion journal to thrombosis and haemostasis, 2019-10, Vol.3 (4), p.e340-e347

2019

Volltextzugriff (PDF)

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

TH open : companion journal to thrombosis and haemostasis, 2019-10, Vol.3 (4), p.e348-e349

2019

Volltextzugriff (PDF)

The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

Hemato, 2022-03, Vol.3 (1), p.204-218

2022

Volltextzugriff (PDF)

Calpastatin Controls Polymicrobial Sepsis by Limiting Procoagulant Microparticle Release

American journal of respiratory and critical care medicine, 2012-04, Vol.185 (7), p.744-755

2012

Volltextzugriff (PDF)

The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation

Thrombosis and haemostasis, 2004-05, Vol.91 (5), p.977-985

2004

Volltextzugriff (PDF)

Analysis of Inter-Observer Agreement of Adjudication of Colors of Pad Colors of Doac Dipstick to Determine Presence or Absence of Direct Oral Anticoagulants in Outpatients' Urine Samples

Blood, 2021-11, Vol.138 (Supplement 1), p.3213-3213

2021

Volltextzugriff (PDF)

The Procoagulant Phospholipid Dependent Clotting Time and the Initiation Phase of Thrombin Generation Test Are Mandatory for the Evaluation of the Risk for Severe Early Onset Preeclampsia

Blood, 2023-11, Vol.142 (Supplement 1), p.5406-5406

2023

Volltextzugriff (PDF)

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Blood, 2022-11, Vol.140 (Supplement 1), p.11211-11213

2022

Volltextzugriff (PDF)

Heterogeneity of synthetic factor Xa inhibitors

Current pharmaceutical design, 2005-01, Vol.11 (30), p.3855-3876

2005

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Aktive Filter

ThemaPeripheral Vascular Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(95)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(31)
Science & Technology
(31)
Life Sciences & Biomedicine
(30)
Life Sciences
(21)
Hematology
(18)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Thrombin Generation
(13)
Female
(12)
Cancer
(11)
Aged
(9)
Middle Aged
(9)
Risk Factors
(8)
Hematologic And Hematopoietic Diseases
(7)
Male
(7)
Oncology
(7)
Tissue Factor
(7)
Hypercoagulability
(6)
Microparticles
(6)
Pharmacology. Drug Treatments
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hematological findings and complications of COVID‐19

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer

The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies

Modelling of thrombin generation under flow in realistic left anterior descending geometries

Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma

Risk of venous thromboembolism in cancer patients: Reality, actuality and perspectives

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

Calpastatin Controls Polymicrobial Sepsis by Limiting Procoagulant Microparticle Release

The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation

Analysis of Inter-Observer Agreement of Adjudication of Colors of Pad Colors of Doac Dipstick to Determine Presence or Absence of Direct Oral Anticoagulants in Outpatients' Urine Samples

The Procoagulant Phospholipid Dependent Clotting Time and the Initiation Phase of Thrombin Generation Test Are Mandatory for the Evaluation of the Risk for Severe Early Onset Preeclampsia

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Heterogeneity of synthetic factor Xa inhibitors

Aktive Filter

Suchergebnisse filtern